This website is fully funded and supported by Gilead Sciences Europe Ltd

 

  • Remdesivir will be given to people with COVID-19. It is suitable for adults and adolescents (aged 12 to <18 years and weighing 40 kg or more). It will only be given to patients who have pneumonia, and need extra oxygen to help them breathe, but who are not on artificial ventilation (where mechanical means are used to assist or replace spontaneous breathing).1

  • REFERENCES AND FOOTNOTES

    COVID-19, coronavirus disease 2019; RDV, remdesivir; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

    1. VEKLURY (RDV) Patient Information Leaflet. July 2021.